KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Range Low Price High Price Comment
30 days $1.91 $2.61 Friday, 26th Apr 2024 CHRS stock ended at $2.04. This is 5.70% more than the trading day before Thursday, 25th Apr 2024. During the day the stock fluctuated 6.74% from a day low at $1.93 to a day high of $2.06.
90 days $1.91 $2.87
52 weeks $1.44 $8.22

Historical Coherus BioSciences prices

Date Open High Low Close Volume
Mar 07, 2016 $18.40 $20.82 $18.40 $19.93 320 900
Mar 04, 2016 $18.02 $19.44 $17.44 $18.46 331 800
Mar 03, 2016 $17.82 $18.08 $16.80 $18.06 259 000
Mar 02, 2016 $15.00 $19.07 $14.92 $17.64 544 500
Mar 01, 2016 $13.85 $15.03 $13.12 $15.02 275 500
Feb 29, 2016 $14.38 $14.89 $14.00 $14.19 279 200
Feb 26, 2016 $13.99 $14.62 $13.98 $14.43 110 300
Feb 25, 2016 $14.04 $14.18 $13.42 $13.82 97 700
Feb 24, 2016 $13.75 $14.07 $13.10 $13.99 209 200
Feb 23, 2016 $14.53 $14.73 $13.85 $13.94 334 300
Feb 22, 2016 $14.81 $14.88 $14.39 $14.60 292 900
Feb 19, 2016 $14.58 $14.72 $13.90 $14.63 210 800
Feb 18, 2016 $15.52 $15.61 $14.52 $14.66 191 300
Feb 17, 2016 $14.80 $16.20 $14.69 $15.41 268 300
Feb 16, 2016 $13.90 $15.27 $13.81 $14.69 244 900
Feb 12, 2016 $13.56 $13.99 $12.80 $13.61 227 000
Feb 11, 2016 $12.48 $13.52 $12.31 $13.34 247 800
Feb 10, 2016 $12.78 $13.67 $12.59 $12.85 217 800
Feb 09, 2016 $12.23 $13.09 $12.04 $12.71 202 100
Feb 08, 2016 $14.02 $14.33 $12.35 $12.54 328 700
Feb 05, 2016 $13.48 $15.28 $13.35 $14.33 807 400
Feb 04, 2016 $12.62 $13.37 $12.42 $13.24 249 800
Feb 03, 2016 $13.26 $13.33 $12.17 $12.75 357 000
Feb 02, 2016 $13.36 $13.59 $12.94 $13.12 664 000
Feb 01, 2016 $13.20 $13.41 $12.34 $13.16 316 600
Click to get the best stock tips daily for free!

About Coherus BioSciences

Coherus BioSciences Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the United States. Its pipeline products include biosimilars of Humira, Avastin, and Lucentis. The company also develops Toripalimab, a novel anti-PD-1 antibody for second-line treatment of melanoma ... CHRS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT